Research Article
Differential Gene Expression Profile of Renin-Angiotensin System in the Left Atrium in Mitral Regurgitation Patients
Table 3
Comparison of mRNA levels through quantitative PCR in the left atria among MR patients with heart failure, aortic valve disease patients with heart failure, and normal controls.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as mean ± SEM; quantitative RT-PCR values are presented in △Cq units; MR: mitral regurgitation; AVD: aortic valve disease; NC: purchased samples from normal subjects. ACE: angiotensin-converting enzyme; ACE2: angiotensin I converting enzyme (peptidyl-dipeptidase A) 2; AT1: angiotensin II receptor, type 1; ENPEP: glutamyl aminopeptidase; AGT: angiotensinogen; CTSA: cathepsin A; THOP1: thimet oligopeptidase 1; NLN: neurolysin, mitochondrial-like; ANPEP: alanyl (membrane) aminopeptidase; CTSG: cathepsin G; LNPEP: leucyl/cystinyl aminopeptidase; MME: neprilysin; CMA1: mast cell protease 2-like; CPA3: carboxypeptidase A3; MAS1: MAS1 oncogene; NR3C2: mineralocorticoid receptor; CYP11B2: aldosterone synthase gene. |